Azurocidin - 0.2mg

Azurocidin - 0.2mg

Regular price
$377.17
Regular price
Sale price
$377.17
Unit price
per 
Availability
Sold out

Heparin-binding protein (HBP)

CAP37
Uniprot ID:  P20160
mRNA RefSeq:  NM_001700
Protein RefSeq:  NP_001691

Size: 0.2mg
Source: Human Neutrophils
Catalogue Number: ATA01-02

Product Information 

Azurocidin a human neutrophil granule protein displays antibacterial and monocyte-specific chemotactic activity. It mobilises rapidly from emigrating polymorphonuclear leukocytes and is an important mediator during initiation of an immune response. With a molecular mass of 37kDa, azurocidin has 45% sequence identity to human neutrophil elastase. However, it is not a serine proteases as it lacks active serine and histidine residues. Azurocidin shows highest homology to elastase in the regions containing eight strictly reserved cysteine residues.
               
Azurocidin has been reported as an early indicator of organ failure and poor neurological outcomes after cardiac arrest with high levels being found in the plasma. Detecting circulatory failure in patients with sepsis is critical for successful treatment. Heparin binding protein released from activated neutrophils is a potent inducer of vascular leakage, monitoring for elevated levels of this protein can help identify the risks of patients developing sepsis when they are in circulatory failure. Similar observations have been made in patients susceptible to ARDS and sepsis after experiencing trauma events.
 

PDF-logo-dl Azurocidin datasheet

Clinical Indications

Plasma azurocidin levels have been found to be elevated in patients with severe sepsis and septic shock.
Azurocidin levels may also be of significance in respiratory failure after trauma, in acute bacterial meningitis and as a predictor of outcome in cardiac arrest
 

MSDS

PDF-logo-dl  Material Safety Data Sheet

References

Pereira H.A. et al (1990) CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest.85:1468-76

Wilde C.G. et al. (1990) Characterization of two azurophil granule proteases with active-site homology to neutrophil elastase. J.Biol. Chem. 265:2038-41

Pohl J. et al. (1990) Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specificchemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett. 272:200-4

Iverson L.F. et al. (1997) Structure of HBP, a multifunctional protein with a serine proteinase fold. Nat. Struct. Biol. 4:265-8

Linder A. et al. (2009) Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin. Infect. Dis. 49:1044-50

Johansson J. et al. (2013) Heparin-binding protein (HBP): an early marker of respiratory failure after trauma? Acta Anaesthesiol.Scand. 57:580-6

Linder A. et al. (2011) Heparin-binding protein: a diagnostic marker for acute bacterial meningitis. Crit. Care Med. 39:812-7

Dankiewicz J. et al. (2013) Heparin-binding protein: an early indicator of critical illness and predictor of outcome in cardiac arrest.Resuscitation 84:935-9